The VEGF_936_C>T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women.
暂无分享,去创建一个
R. Scott | U. Hamann | A. Jakubowska | J. Lubiński | L. Edler | T. Byrski | T. Huzarski | J. Gronwald | B. Górski | J. Menkiszak | R. Scott
[1] R. Scott,et al. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks , 2007, Breast Cancer Research and Treatment.
[2] X. Shu,et al. Population-Based Case-Control Study of VEGF Gene Polymorphisms and Breast Cancer Risk among Chinese Women , 2006, Cancer Epidemiology Biomarkers & Prevention.
[3] J. Isaacs,et al. BRCA1 Plays a Role in the Hypoxic Response by Regulating HIF-1α Stability and by Modulating Vascular Endothelial Growth Factor Expression* , 2006, Journal of Biological Chemistry.
[4] M. Thun,et al. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort , 2006, Breast Cancer Research.
[5] K. Hemminki,et al. Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis , 2005, Clinical Cancer Research.
[6] U. Langsenlehner,et al. The 936C>T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake , 2004, Breast Cancer Research and Treatment.
[7] B. Górski,et al. Vascular endothelial growth factor (VEGF) levels and mutation of the BRCA1 gene in breast cancer patients , 2004, Breast Cancer Research and Treatment.
[8] A. Jakubowska,et al. A high proportion of founder BRCA1 mutations in Polish breast cancer families , 2004, International journal of cancer.
[9] C. Dabrosin,et al. Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo. , 2003, Cancer research.
[10] B. Paulweber,et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk , 2003, International journal of cancer.
[11] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[12] M. Reed,et al. Role of genetic polymorphisms in tumour angiogenesis , 2002, British Journal of Cancer.
[13] H. Kawai,et al. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells , 2002, Oncogene.
[14] N. Ferrara,et al. The Role of Vascular Endothelial Growth Factor in Angiogenesis , 2002, Acta Haematologica.
[15] W. Renner,et al. A Common 936 C/T Mutation in the Gene for Vascular Endothelial Growth Factor Is Associated with Vascular Endothelial Growth Factor Plasma Levels , 2000, Journal of Vascular Research.
[16] A. Jakubowska,et al. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. , 2000, American journal of human genetics.
[17] R. Henriksson,et al. p53 and vascular‐endothelial‐growth‐factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma , 2000, International journal of cancer.
[18] R. Henriksson,et al. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] L. Twiggs,et al. Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas. , 1997, Cancer letters.
[20] Anthony J. Guidi,et al. Vascular permeability factor (Vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast , 1997, Cancer.
[21] L. Twiggs,et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma , 1997, Cancer.
[22] Y. Meng,et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. , 1996, The Journal of clinical endocrinology and metabolism.
[23] D. Gomez,et al. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. , 1996, Cancer research.
[24] D. Lahiri,et al. DNA isolation by a rapid method from human blood samples: Effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality , 2004, Biochemical Genetics.
[25] M. Perrot-Applanat,et al. Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation , 2004, Angiogenesis.